Search by Drug Name or NDC

    NDC 63739-0159-10 Mag Al Plus 200; 20; 200 mg/5mL; mg/5mL; mg/5mL Details

    Mag Al Plus 200; 20; 200 mg/5mL; mg/5mL; mg/5mL

    Mag Al Plus is a ORAL SUSPENSION in the HUMAN OTC DRUG category. It is labeled and distributed by McKesson Corporation dba as SKY Packaging. The primary component is ALUMINUM HYDROXIDE; DIMETHICONE; MAGNESIUM HYDROXIDE.

    Product Information

    NDC 63739-0159
    Product ID 63739-159_e26d6e45-b801-052d-e053-2a95a90ade6d
    Associated GPIs
    GCN Sequence Number 002701
    GCN Sequence Number Description mag hydrox/aluminum hyd/simeth ORAL SUSP 200-200-20 ORAL
    HIC3 D4B
    HIC3 Description ANTACIDS
    GCN 63910
    HICL Sequence Number 001168
    HICL Sequence Number Description MAGNESIUM HYDROXIDE/ALUMINUM HYDROXIDE/SIMETHICONE
    Brand/Generic Generic
    Proprietary Name Mag Al Plus
    Proprietary Name Suffix n/a
    Non-Proprietary Name ALUMINUM HYDROXIDE, MAGNESIUM HYDROXIDE, and DIMETHICONE
    Product Type HUMAN OTC DRUG
    Dosage Form SUSPENSION
    Route ORAL
    Active Ingredient Strength 200; 20; 200
    Active Ingredient Units mg/5mL; mg/5mL; mg/5mL
    Substance Name ALUMINUM HYDROXIDE; DIMETHICONE; MAGNESIUM HYDROXIDE
    Labeler Name McKesson Corporation dba as SKY Packaging
    Pharmaceutical Class Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity
    DEA Schedule n/a
    Marketing Category OTC MONOGRAPH FINAL
    Application Number part331
    Listing Certified Through 2023-12-31

    Package

    NDC 63739-0159-10 (63739015910)

    NDC Package Code 63739-159-10
    Billing NDC 63739015910
    Package 10 TRAY in 1 CASE (63739-159-10) / 10 CUP, UNIT-DOSE in 1 TRAY / 30 mL in 1 CUP, UNIT-DOSE (63739-159-77)
    Marketing Start Date 2022-07-01
    NDC Exclude Flag N
    Pricing Information N/A

    Standard Product Labeling (SPL)/Prescribing Information SPL b6ec516a-296f-4521-8825-46e39f40efbe Details

    Revised: 6/2022